Literature DB >> 10482092

The VF-14 index of functional visual impairment in candidates for a corneal graft.

H Boisjoly1, J Gresset, N Fontaine, M Charest, I Brunette, M LeFrançois, J Deschênes, R Bazin, P A Laughrea, I Dubé.   

Abstract

PURPOSE: To validate the Visual Function-14 (VF-14) index of functional visual impairment in candidates for a corneal graft.
METHODS: One hundred thirty-four patients who were candidates for a corneal graft participated in this study between August 1996 and February 1997. Demographic, ocular history, best-corrected visual acuity, and detailed ocular examination data were collected. Functional visual impairment information was obtained by telephone interviews using the following: VF-14, SF-36 (Short Form-36, a more generic measure of general health function), and Visual Symptom Score, and four questions measuring the overall amount of trouble with vision, dissatisfaction with vision, ocular pain, and discomfort.
RESULTS: The average age of corneal graft candidates was 64 +/- 18 years (range, 18 to 90 years) and 60% were women. The most frequent corneal disease was pseudophakic bullous keratopathy (41%). Ocular comorbidities included glaucoma or ocular hypertension (30%) and cataract (19%). The mean best-corrected visual acuity of the eye scheduled for surgery was 1.33 +/- 0.56 logMAR whereas the best eye best-corrected visual acuity was 0.36 +/- 0.44 logMAR. The mean VF-14 score was 73% +/- 26%, and the internal consistency was high, with a Cronbach alpha value of 0.94. The VF-14 correlated strongly with the best eye best-corrected visual acuity. It also correlated strongly with the Visual Symptom Score, the global measures of trouble and dissatisfaction with vision. Candidates for a corneal graft had low scores for all eight general health concepts evaluated with the SF-36, and the VF-14 correlated with seven of the eight SF-36 subscales.
CONCLUSION: The VF-14 is a valid measure of functional visual impairment in candidates for a corneal graft. The Visual Symptom Score and the SF-36 are also useful indices in such patients.

Entities:  

Mesh:

Year:  1999        PMID: 10482092     DOI: 10.1016/s0002-9394(99)00071-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Quality of life and visual function in patients with intermediate uveitis.

Authors:  C C Murphy; E H Hughes; N A Frost; A D Dick
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Social and visual function in nystagmus.

Authors:  R F Pilling; J R Thompson; I Gottlob
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  The measurement of patient-reported outcomes of refractive surgery: the refractive status and vision profile.

Authors:  O D Schein
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 4.  Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review.

Authors:  Mary Kay Margolis; Karin Coyne; Tessa Kennedy-Martin; Timothy Baker; Oliver Schein; Dennis A Revicki
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 5.  Quality of life in glaucoma and three other chronic diseases: a systematic literature review.

Authors:  Tim Mills; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  [Measuring patient's quality of life in ophthalmology].

Authors:  C Hirneiss; A S Neubauer; U Welge-Lüssen; K Eibl; A Kampik
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

7.  The Association of the Prevalence of Depression in Type 2 Diabetes Mellitus with Visual-Related Quality of Life and Social Support.

Authors:  Xiaoxia Ding; Shisong Rong; Yu Wang; Dong Li; Liang Wen; Bo Zou; Dongxiao Zang; Kemi Feng; Yuanbo Liang; Fenghua Wang; Gang Zhai
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-22       Impact factor: 3.168

8.  Development and validation of an Arabic version of the Visual Functioning Index VF-14 for cataract patients.

Authors:  Ahmed Mousa; Ali H Al Ghamdi; Hatem Kalantan; Abdul R Al Muammar
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.